TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9831696

Group type: EXPERIMENTAL
Intervention: nisoldipine (20-40 mg once daily)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: lisinopril (10-20 mg once daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: control group (normotensive healthy subjects)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: nisoldipine and lisinopril (compared to each other)
Number of subjects: 48
Study: 7990347

Group type: EXPERIMENTAL
Intervention: Leukinferon administered intramuscularly for 10 days (day 1: 3 samples, day 2: 2 ampules, day 3: 1 ampule daily, total 1 x 10(5) U of interferon)
Number of subjects: 30
Study: 2524327

Group type: EXPERIMENTAL
Intervention: netilmicin 200 mg daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: netilmicin 200 mg + ampicillin 1 g daily
Number of subjects: 30
Study: 31918668

Group type: EXPERIMENTAL
Intervention: Proximal intercostal block (n = 32)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Paravertebral block (n = 26)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Proximal intercostal block
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Proximal intercostal and Paravertebral blocks)
Number of subjects: 20
Study: 29703044

Group type: EXPERIMENTAL
Intervention: Aspiration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Deroofing
Number of subjects: 40
Study: 28377023

Group type: EXPERIMENTAL
Intervention: Percutaneous ultrasound-guided rectus sheath block (PERC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Intraoperative rectus sheath block (IO)
Number of subjects: 58
Study: 25838206

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D
Number of subjects: 776
Study: 23541643

Group type: EXPERIMENTAL
Intervention: Dose level I: 69 Gy in 30 fractions of 2.3 Gy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Dose level II: 72 Gy in 30 fractions of 2.4 Gy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Dose level III: 75 Gy in 30 fractions of 2.5 Gy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 57
Study: 22014101

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) 100,000 IU every 4 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 19495544

Group type: EXPERIMENTAL
Intervention: Oxybutynin (2.5 mg) three times per day
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Vaginal electric stimulation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 16923001

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cephalic venotomy technique
Number of subjects: 98
Study: 15181050

Group type: EXPERIMENTAL
Intervention: eplerenone 50 mg/d
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: eplerenone 100 mg/d
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: eplerenone 200 mg/d
Number of subjects: 397

Group type: COMPARATOR
Intervention: nonresponders
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: eplerenone (all doses)
Number of subjects: 397
Study: 11230886

Group type: EXPERIMENTAL
Intervention: XRT+EBB (External irradiation plus endobronchial brachytherapy)
Number of subjects: 95

Group type: COMPARATOR
Intervention: XRT (External irradiation alone)
Number of subjects: 95
Study: 9027779

Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg daily, n = 24)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 53
Study: 8391513

Group type: EXPERIMENTAL
Intervention: SCH 42495 (200 mg, every 12 hours)
Number of subjects: 8
Study: 3090614

Group type: EXPERIMENTAL
Intervention: Routine use of scout films
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Selective use of scout films
Number of subjects: 1001
Study: 30113538

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 66
Study: 27259970

Group type: EXPERIMENTAL
Intervention: Sodium naproxen 550 mg b.i.d. plus rebamipide 100 mg b.i.d.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sodium naproxen 550 mg b.i.d. plus placebo
Number of subjects: 24
Study: 24667035

Group type: EXPERIMENTAL
Intervention: Low-sodium, high-potassium salt substitute
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis of the implementation strategy
Number of subjects: 0
Study: 22697333

Group type: EXPERIMENTAL
Intervention: Helical Tomotherapy (HT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Step‐and‐shoot IMRT
Number of subjects: 12
Study: 20142308

Group type: EXPERIMENTAL
Intervention: R213129 3 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: R213129 10 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 18052708

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM) graft and coronally positioned flap (CPF)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Coronally positioned flap (CPF) alone
Number of subjects: 14
Study: 15763574

Group type: EXPERIMENTAL
Intervention: Alcohol (24 g ethyl alcohol, 1508 kJ, 405 ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No-alcohol (867 kJ, 405 ml)
Number of subjects: 12
Study: 12046033

Group type: EXPERIMENTAL
Intervention: Simvastatin, 20 mg/d for 8 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 11783153

Group type: EXPERIMENTAL
Intervention: Puerarin (600 mg intravenously, once daily for one week)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (same treatment as treated group, but without puerarin)
Number of subjects: 48
Study: 7825526

Group type: EXPERIMENTAL
Intervention: Hypolipidemic diet rich in monounsaturated fatty acids (MUFA) for 12 weeks
Number of subjects: 122
Study: 2109445

Group type: EXPERIMENTAL
Intervention: Pyridostigmine 120 mg orally one hour prior to GHRH (100 micrograms iv)
Number of subjects: 12

Group type: COMPARATOR
Intervention: GHRH (100 micrograms iv) alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms iv) with pyridostigmine (120 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GHRH (higher doses) or pyridostigmine (higher doses)
Number of subjects: 12
Study: 396673

Group type: EXPERIMENTAL
Intervention: Brinase (thrombolytic enzyme)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 27
Study: 30146268

Group type: EXPERIMENTAL
Intervention: Lumacaftor/Ivacaftor (LUM/IVA) 400 mg q12h / 250 mg q12h
Number of subjects: 369
Study: 27405732

Group type: EXPERIMENTAL
Intervention: Combined modality treatment (CMT)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Subtotal lymphoid irradiation (STLI)
Number of subjects: 239
Study: 23692587

Group type: EXPERIMENTAL
Intervention: High-dose paracetamol (6 grams daily for three consecutive days)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo (matching placebo for three consecutive days)
Number of subjects: 1500
Study: 23545371

Group type: EXPERIMENTAL
Intervention: GERD diagnosis with no effectiveness information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GERD diagnosis with effectiveness information
Number of subjects: 0

Group type: COMPARATOR
Intervention: No disease label with no effectiveness information
Number of subjects: 0

Group type: COMPARATOR
Intervention: No disease label with effectiveness information
Number of subjects: 0
Study: 21953763

Group type: EXPERIMENTAL
Intervention: HDLI (higher demand dose with low constant infusion)
Number of subjects: 38

Group type: COMPARATOR
Intervention: LDHI (lower demand dose and higher constant infusion)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: HDLI
Number of subjects: 38

Group type: COMPARATOR
Intervention: LDHI
Number of subjects: 38
Study: 18187214

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: No statin treatment (Control)
Number of subjects: 24
Study: 17563167

Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive-behavioral therapy (T-CBT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Telephone-administered supportive emotion focused therapy (T-SEFT)
Number of subjects: 97
Study: 15845678

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia at concentrations of 0.7%, 1.4%, and 2.0%
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 9
Study: 12692006

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 14
Study: 10588412

Group type: EXPERIMENTAL
Intervention: Outpatient commitment
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Sustained outpatient commitment
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Sustained outpatient commitment with higher intensity of outpatient treatment
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group (released subjects)
Number of subjects: 264
Study: 8537594

Group type: EXPERIMENTAL
Intervention: A.G.E. dementia care program
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual nursing home care (Control)
Number of subjects: 81
Study: 1681722

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 47

Group type: COMPARATOR
Intervention: No Heparin
Number of subjects: 47
Study: 6759144

Group type: EXPERIMENTAL
Intervention: Alinidine 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31537880

Group type: EXPERIMENTAL
Intervention: Dactavira (SOF 400mg/DCV 60mg/EGCG 400mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Dactavira plus (SOF 400mg/DCV 60mg/EGCG 400mg/RBV 800mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard of care (SOF 400mg/DCV 60mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard of care + RBV (SOF 400mg/DCV 60mg/RBV 800mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Dactavira or Dactavira plus
Number of subjects: 72
Study: 28488080

Group type: EXPERIMENTAL
Intervention: PBB-VPC
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: PBB-HPH
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study: 25428511

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric imbrication (LGI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 30
Study: 24611484

Group type: EXPERIMENTAL
Intervention: UP446 (500 mg/day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: naproxen (440 mg/day)
Number of subjects: 79
Study: 22143314

Group type: EXPERIMENTAL
Intervention: Immediate full weight bearing
Number of subjects: 37

Group type: COMPARATOR
Intervention: Partial weight bearing for three months
Number of subjects: 37
Study: 19272084

Group type: EXPERIMENTAL
Intervention: Early pulmonary rehabilitation
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Early pulmonary rehabilitation (attendees)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 97
Study: 17239062

Group type: EXPERIMENTAL
Intervention: Community-based stroke prevention programme (eight weekly two-hour sessions)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 190
Study: 15057896

Group type: EXPERIMENTAL
Intervention: Continuous catheter drainage (8F multi‐sidehole pigtail catheter)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intermittent needle aspiration (18G disposable trocar needle)
Number of subjects: 64
Study: 12500884

Group type: EXPERIMENTAL
Intervention: Enoxaparin prophylaxis
Number of subjects: 0
Study: 9585772

Group type: EXPERIMENTAL
Intervention: Broad spectrum antimicrobial therapy and operation
Number of subjects: 429
Study: 7896992

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg) available to all participants
Number of subjects: 3923

Group type: EXPERIMENTAL
Intervention: Nicotine gum use at 12 months
Number of subjects: 3923

Group type: EXPERIMENTAL
Intervention: Greater social and environmental support for quitting smoking
Number of subjects: 3923

Group type: EXPERIMENTAL
Intervention: Baseline variables associated with initial quitting
Number of subjects: 3923

Group type: EXPERIMENTAL
Intervention: Smoking at least 1 cigarette between quit day and 4 months
Number of subjects: 3923
Study: 2172376

Group type: EXPERIMENTAL
Intervention: 40 min of bicycle exercise three times per week at 60‐70% of maximum work for 12 weeks
Number of subjects: 10
Study: 629073

Group type: EXPERIMENTAL
Intervention: mepindolol-sulfate
Number of subjects: 5

Group type: COMPARATOR
Intervention: propranolol
Number of subjects: 5
Study: 30548890

Group type: EXPERIMENTAL
Intervention: Consultation Planning, Recording and Summarising (CPRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 28541285

Group type: EXPERIMENTAL
Intervention: Blockade of opioidergic circuit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological challenge of opioid receptor function
Number of subjects: 0
Study: 25872507

Group type: EXPERIMENTAL
Intervention: Acupuncture at Fengchi (GB 20) with twirling at 60 times per minute toward the contralateral outer canthus at a depth of 0.5 to 0.8 cun
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Acupuncture at Fengchi (GB 20) with twirling at 60 times per minute toward the Adam's apple at a depth of 0.5 to 0.8 cun
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Acupuncture at Fengchi (GB 20) with twirling at 120 times per minute toward the contralateral outer canthus at a depth of 0.5 to 0.8 cun
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Acupuncture at Fengchi (GB 20) with twirling at 120 times per minute toward the Adam's apple at a depth of 0.5 to 0.8 cun
Number of subjects: 144
Study: 23637069

Group type: EXPERIMENTAL
Intervention: Occupational therapy programme for care home staff to increase activity provision
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 210
Study: 21113789

Group type: EXPERIMENTAL
Intervention: NW + 0.5 kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NW + 1.5 kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NW
Number of subjects: 12

Group type: COMPARATOR
Intervention: W
Number of subjects: 12
Study: 19594087

Group type: EXPERIMENTAL
Intervention: 50 g CHO in 400 ml of water
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.5 g aspartam in 100 ml of water (Control)
Number of subjects: 200
Study: 16772250

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Health Education (Control)
Number of subjects: 103
Study: 15487740

Group type: EXPERIMENTAL
Intervention: Functional-imaging-weighted equivalent uniform dose (fEUD) calculation using FDG-PET activity as a surrogate for tumor cell density
Number of subjects: 31

Group type: COMPARATOR
Intervention: Equivalent uniform dose (EUD) calculation assuming uniform tumor cell density
Number of subjects: 31
Study: 11598557

Group type: EXPERIMENTAL
Intervention: Misoprostol with oxytocin infusion
Number of subjects: 90

Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 90
Study: 9440361

Group type: EXPERIMENTAL
Intervention: Memory for visual target location over a range of 4-30 seconds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encoding of a second location presented sequentially
Number of subjects: 0
Study: 7700063

Group type: COMPARATOR
Intervention: Cilazapril 1-5 mg once daily for 12 weeks
Number of subjects: 1163

Group type: EXPERIMENTAL
Intervention: Cilazapril 0.5-15 mg once daily
Number of subjects: 1163

Group type: EXPERIMENTAL
Intervention: Cilazapril therapy
Number of subjects: 1163
Study: 3038254

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg daily for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31952073

Group type: EXPERIMENTAL
Intervention: Bubble CPAP (b-CPAP) bundle of care
Number of subjects: 773

Group type: COMPARATOR
Intervention: Initial management with CPAP
Number of subjects: 773
Study: 29632227

Group type: EXPERIMENTAL
Intervention: Engagement materials developed through Boot Camp Translation (BCT) involving community members, practice members, and public health professionals.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard practice facilitation support
Number of subjects: 0
Study: 27013483

Group type: EXPERIMENTAL
Intervention: PlayForward videogame intervention
Number of subjects: 333

Group type: COMPARATOR
Intervention: Control games
Number of subjects: 333
Study: 25639570

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (PE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Present-Centered therapy (PCT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High treatment responders (collapsed across treatments)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High treatment responders (mid-treatment)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Thoughts of incompetence (high treatment responders)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Thoughts of a dangerous world (high treatment responders)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Script-associated cortisol response prior to treatment and reductions in thoughts of incompetence
Number of subjects: 36
Study: 23413013

Group type: EXPERIMENTAL
Intervention: Auditory imagery self-report questionnaire (Bucknell Auditory Imagery Scale)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pitch discrimination task
Number of subjects: 0
Study: 21920193

Group type: EXPERIMENTAL
Intervention: Personalized counseling on contraceptive acceptability
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group (no personalized counseling)
Number of subjects: 246
Study: 18487911

Group type: EXPERIMENTAL
Intervention: Cetuximab with radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetuximab with 5-FU and cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-FU and cisplatin alone
Number of subjects: 0
Study: 17057622

Group type: EXPERIMENTAL
Intervention: Ultrasound monitoring of the cycle alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard monitoring including hormone assays and ultrasound
Number of subjects: 0
Study: 12745440

Group type: EXPERIMENTAL
Intervention: Intersensory paired‐preference procedure
Number of subjects: 0
Study: 12419788

Group type: EXPERIMENTAL
Intervention: High-fiber supplement (13.5 g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fiber supplement (2.0 g/day)
Number of subjects: 0
Study: 10321445

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy change due to inadequate blood pressure control
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy change due to adverse effects
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy change due to patient dissatisfaction
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy change due to non-compliance
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy change due to cost
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Adverse effects reported by physicians
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Patient compliance assessment
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Reasons for non-compliance as assessed by patients
Number of subjects: 1603
Study: 7706963

Group type: EXPERIMENTAL
Intervention: Iodine fortified fish sauce
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iodinated salt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Ban Non Sa‐aad)
Number of subjects: 0
Study: 2691818

Group type: EXPERIMENTAL
Intervention: Body hair removal (EXP group)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 9
Study: 5082546

Group type: EXPERIMENTAL
Intervention: Erect position
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 0
Study: 27644137

Group type: EXPERIMENTAL
Intervention: ω-3-rich enteral nutrition (900 mg of ω-3 fatty acids)
Number of subjects: 61

Group type: COMPARATOR
Intervention: ω-3-poor enteral nutrition (250 mg of ω-3 fatty acids)
Number of subjects: 61
Study: 25245781

Group type: EXPERIMENTAL
Intervention: Fresh-frozen bone allograft (FFB) combined with bovine bone mineral (BBM) at a 2:1 ratio
Number of subjects: 29

Group type: COMPARATOR
Intervention: Allograft bone (control group)
Number of subjects: 29
Study: 23359310

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (4.5 mg/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 21062392

Group type: EXPERIMENTAL
Intervention: Naftopidil 75 mg/day for 6 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 82
Study: 19926556

Group type: EXPERIMENTAL
Intervention: Pharmacist‐provided intervention to improve heart failure medication adherence
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 314
Study: 17493465

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PPCI)
Number of subjects: 2781

Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 2781

Group type: EXPERIMENTAL
Intervention: PPCI
Number of subjects: 2781
Study: 15792021

Group type: EXPERIMENTAL
Intervention: Sevoflurane for laryngeal mask insertion (LMI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane for tracheal intubation (TI)
Number of subjects: 30
Study: 11302464

Group type: EXPERIMENTAL
Intervention: Alternated basketball
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alternated running
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control, adapted physical activity
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control, sedentary
Number of subjects: 32
Study: 10374274

Group type: EXPERIMENTAL
Intervention: Fluconazole (Flu) 200-400 mg daily for 1-8 weeks
Number of subjects: 222

Group type: COMPARATOR
Intervention: Ketoconazole (Keto) 400 mg daily for 1-8 weeks
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Fluconazole (Flu) in open trial (150 mg single dose for fungal vaginitis)
Number of subjects: 222
Study: 7885486

Group type: EXPERIMENTAL
Intervention: Empirically-designed nursing practice model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control unit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental unit
Number of subjects: 0